{"id":"W2035360235","doi":"10.1016/j.ctrv.2006.01.005","title":"Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence","year":2006,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Adjuvant; Internal medicine; Chemotherapy; Stage (stratigraphy); Metastatic breast cancer; Monoclonal antibody; Cancer; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003533179,0.0002147458,0.0009942903,0.0002395012,0.0001243045,0.0002719946,0.0002346756,0.0002981437,0.003389439],"category_scores_gemma":[0.001468392,0.00008612974,0.000333248,0.0002244155,0.00008035713,0.0001997084,0.0001045017,0.0005584863,0.0003378411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003041217,"about_ca_system_score_gemma":0.0002689119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007756127,"about_ca_topic_score_gemma":0.002575928,"domain_scores_codex":[0.9998522,0.00005670382,0.00001011417,0.00001344606,0.00003554259,0.00003199543],"domain_scores_gemma":[0.9996678,0.0001456747,0.00008536693,0.00001813408,0.00003213226,0.00005088294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01725969,0.001718164,0.009024145,0.00098039,0.0006387202,0.0003607919,0.000149233,0.0005402932,0.01068137,0.0002970195,0.01543206,0.942918],"study_design_scores_gemma":[0.01792747,0.09631032,0.677332,0.001125538,0.006481308,0.007010523,0.0004897955,0.002425812,0.03047713,0.001569298,0.158772,0.00007875214],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7213358,0.2629949,0.0007073399,0.003521391,0.0009273031,0.00007791484,0.0002037256,0.0001513142,0.01008032],"genre_scores_gemma":[0.9313498,0.05843965,0.0004810924,0.0008975586,0.0006925772,0.00003923535,0.0002278207,0.0000281563,0.007844206],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.003389439,"threshold_uncertainty_score":0.01133883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06632819832425466,"score_gpt":0.4043932864000384,"score_spread":0.3380650880757837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}